| Zacks Company Profile for Scienture Holdings, Inc. (SCNX : NSDQ) |
|
|
| |
| Company Description |
| Scienture Holdings Inc., through its wholly owned subsidiaries, Scienture and Integra Pharma Solutions, LLC, is a comprehensive pharmaceutical product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy unmet market needs. Scienture Holdings Inc., formerly known as TRxADE Health Inc., is based in TAMPA, FL.
Number of Employees: 19 |
|
|
| |
| Price / Volume Information |
| Yesterday's Closing Price: $0.73 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 66,485,928 shares |
| Shares Outstanding: 34.47 (millions) |
| Market Capitalization: $25.32 (millions) |
| Beta: 3.04 |
| 52 Week High: $8.72 |
| 52 Week Low: $0.46 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
4.76% |
2.02% |
| 12 Week |
-39.30% |
-41.81% |
| Year To Date |
-87.86% |
-89.39% |
|
|
|
|
| |
| Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
20 Austin Blvd. - Commack,NY 11725 USA |
ph: 631-670-6039 fax: 800-265-6932 |
ir@scienture.com |
https://scienture.com |
|
|
| |
| General Corporate Information |
Officers
Surendra Ajjarapu - Chairman and Chief Executive Officer
Prashant Patel - President and Chief Operating Officer
Eric Sherb - Chief Financial Officer
Donald G. Fell - Director
Mayur Doshi - Director
|
|
Peer Information
Scienture Holdings, Inc. (GSAC)
Scienture Holdings, Inc. (CASI)
Scienture Holdings, Inc. (ALCD.)
Scienture Holdings, Inc. (OMNN)
Scienture Holdings, Inc. (CGPI.)
Scienture Holdings, Inc. (CATX)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 80880X104
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/12/25
|
|
Share - Related Items
Shares Outstanding: 34.47
Most Recent Split Date: 6.00 (0.07:1)
Beta: 3.04
Market Capitalization: $25.32 (millions)
|
|
|
|
|
| |
| EPS Information |
Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 11/12/25 |
|
|
|
| |